DUOTRAV Trademark

Trademark Overview

On Thursday, March 17, 2016, a trademark application was filed for DUOTRAV with the United States Patent and Trademark Office. The USPTO has given the DUOTRAV trademark a serial number of 86944325. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 15, 2024. This trademark is owned by Novartis AG. The DUOTRAV trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic pharmaceutical preparations for the treatment of glaucoma
duotrav

General Information

Serial Number86944325
Word MarkDUOTRAV
Filing DateThursday, March 17, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 15, 2024
Registration Number5273915
Registration DateTuesday, August 29, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements

Goods and ServicesOphthalmic pharmaceutical preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events

Event DateEvent Description
Friday, March 15, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 29, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 5, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, April 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 6, 2017ASSIGNED TO LIE
Wednesday, March 22, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 24, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 24, 2016LETTER OF SUSPENSION E-MAILED
Thursday, November 24, 2016SUSPENSION LETTER WRITTEN
Wednesday, November 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2016NON-FINAL ACTION WRITTEN
Sunday, May 22, 2016ASSIGNED TO EXAMINER
Tuesday, March 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2016NEW APPLICATION ENTERED

Related Keywords

duotrav glaucoma treatment preparations pharmaceutical ophthalmic